VRDN
Viridian Therapeutics Inc.
$15.38
$0.00(0.00%)
42
Overall
60
Value
36
Tech
31
Quality
Market Cap
$1.59B
Volume
2.72M
52W Range
$9.90 - $34.29
Target Price
$37.76
EPS Estimates Overview
| Current Quarter | $-1.05 | Next Quarter | $-0.86 |
| Current Year | $-3.56 | Next Year | $-1.89 |
| QoQ Growth | +18.1% | YoY Growth | +46.9% |
| 3Y EPS CAGR | +22.8% | Target Price | $37.76 |
| Consensus | Buy | Upside | +145.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $15.38 | 0% | 2.72M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW